Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-19

Clinical Trial Update: Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of alendronate (Fosamax) in children with osteoporosis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSAMAX (ALENDRONATE SODIUM)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2011-01-19